Secondary hemophagocytic lymphohistiocytosis due to nivolumab/ipilimumab in a renal cell cancer patient-A case report.

导出 LinkOut

翻译打印收藏纠错

第一作者： Adeel,Masood

第一单位： Masters of Public Health in Epidemiology at the University of Alabama at Birmingham Alabama USA.;Tidal Health Peninsula Regional Salisbury Maryland USA.

作者： Adeel,Masood ^[1] ; Ahsan,Wahab ^[2] ; Tanya,Clifford ^[3] ; Eric J,Weaver ^[3] ; Hamid,Ehsan ^[4] ; Walid,El Ayass ^[3]

作者单位： Masters of Public Health in Epidemiology at the University of Alabama at Birmingham Alabama USA.;Tidal Health Peninsula Regional Salisbury Maryland USA. ^[1] Baptist Medical Center South University of Alabama at Birmingham Montgomery Alabama USA. ^[2] Tidal Health Peninsula Regional Salisbury Maryland USA. ^[3] Levine Cancer Institute/Atrium Health Charlotte North Carolina USA. ^[4]

关键词 HLH hematology/oncology immune checkpoint inhibitors ipilimumab nivolumab pembrolizumab secondary hemophagocytic lymphohistiocytosis

DOI 10.1002/ccr3.5184

PMID 34917381

发布时间 2024-04-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical case reports

2021年9卷12期

e05184页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Secondary hemophagocytic lymphohistiocytosis due to nivolumab/ipilimumab in a renal cell cancer patient-A case report.

Clinical case reports

相似文献

Clinical case reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Secondary hemophagocytic lymphohistiocytosis due to nivolumab/ipilimumab in a renal cell cancer patient-A case report.

Clinical case reports

相似文献

Clinical case reports

相关期刊

检索历史清除